about
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System disc...
Read More
1.86
0.03
(1.64%)
343.7K
XNAS Volume
XNAS 27 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Biomea Fusion Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..